Pitt B., Segal R., Martinez FA et al. Randomised trial of losartan vs captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet1997;349:747-752.2.
2.
Pitt B., Poole-Wilson P., Segal R. et al. Effects of Losartan versus Captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II. J Cardiac Failure1999;5:146-154.
3.
Pfeffer M., Swedberg K., Granger C. et al. Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM). J Cardiac Failure1999 ;5:276-282.
4.
Dickstein K. , Kjekshus J., OPTIMAAL Study GroupComparison of the effects of losartan and captopril on mortality in patients following acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Am J Cardiol1999;83:477-481.
5.
Cohn JN,Tognoni G., Glazer RD et al. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Cardiac Failure1999;5:155-160.
6.
McKelvie RS,Yusuf S., Pericak D. et al. Comparison of candesartan, enalapril and their combination in congestive heart failure: Randomised Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Circulation1999;100:1056-1064.
7.
Rousseau MF, Konstam MA, Benedict CR et al. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor . Am J Cardiol1994;73:489-493.
8.
Urata H., Boehm KD, Phillip A. et al. Cellular localisation and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest1993;91:1269-1281.
9.
Seyedi N.,Win T.,Lander HM, Levi R.Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine / paracrine mechanisms . Circ Res1997;81:774-784.
10.
Minisi AJ, Thames MDDistribution of left ventricular sympathetic afferent demonstrated by reflex responses to transmural myocardial ischaemia and to intracoronary and epicardial bradykinin. Circulation1993 ;87:240-246.
